Market Size of Bioprocess Analyzers Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 2.00 Billion |
Market Size (2029) | USD 4.17 Billion |
CAGR (2024 - 2029) | 15.80 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bioprocess Analyzers Market Analysis
The Bioprocess Analyzers Market size is estimated at USD 2 billion in 2024, and is expected to reach USD 4.17 billion by 2029, growing at a CAGR of 15.80% during the forecast period (2024-2029).
The pandemic had an effect on the market studied. Factors such as high titer, constant product quality, the robustness of the process, fast turnaround times, and scalability are some of the reasons why bioprocess containers are being used in vaccine production. There are many companies whose products are being used for COVID-19 vaccine research. With the large-scale vaccination programs around the world and the new investments in the biopharmaceutical industry, the market studied is expected to regain its potential over the years.
The major factors attributed to the growth of the market are the growing interest in the development of advanced medicines and vaccines and the increasing demand for biologics. These factors are expected to increase the market's growth. The rising geriatric population is susceptible to chronic diseases, which is increasing the demand for biologics. Cardiovascular disease is one of the leading causes of death globally, in which myocardial infarction (MI) is a major event. According to the article published in March 2021 by the National Library of Medicine, current therapies do not adequately address the multiple dysregulated systems following MI. The research to develop drug delivery systems for biologics is expected to increase over the forecast period, positively impacting the growth of the market. The increasing investments by the major market players in the development of biologics are driving the market's growth. In 2022, Aurobindo Pharma (CuraTeQ Biologics) planned to invest around INR 300 crore in capacity expansion of biologics manufacturing facilities, and this facility is likely to be fully operational by 2026. Furthermore, biologics is efficient in treating rheumatoid arthritis and Crohn's disease, which may lead to the growth of bioprocess analyzers in the production process of biological products. Thus, the aforementioned factors are expected to increase the market's growth during the forecast period.
However, difficulties faced during the upstream and downstream process due to the small-sized bioprocessing equipment and the relatively high cost of the raw materials are constraints to the growth of the market.
Bioprocess Analyzers Industry Segmentation
As per the scope of the report, bioprocess is a technique used to produce biological products, such as microbial genetic strain, and commercially useful chemicals through a biological process.
The bioprocess analyzers market is segmented by product (instruments and consumables), application (antibiotics, recombinant proteins, biosimilars, and other applications), type (substrate analysis, metabolite analysis, and concentration detection), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.
By Product | |
Instruments | |
Consumables |
By Application | |
Antibiotics | |
Recombinant Proteins | |
Biosimilars | |
Other Applications |
By Type | |
Substrate Analysis | |
Metabolite Analysis | |
Concentration Detection |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bioprocess Analyzers Market Size Summary
The bioprocess analyzers market is poised for significant growth, driven by the increasing demand for advanced medicines and biologics. The market is experiencing a resurgence due to the heightened interest in vaccine production and the biopharmaceutical industry's expansion following the pandemic. Factors such as high titer, consistent product quality, and scalability are pivotal in the adoption of bioprocess containers, particularly in vaccine manufacturing. The rising geriatric population and the prevalence of chronic diseases are further propelling the demand for biologics, which in turn is expected to bolster the market for bioprocess analyzers. Investments by major players in biologics development and the strategic collaborations among companies are also contributing to the market's upward trajectory.
North America is anticipated to maintain a substantial share of the bioprocess analyzers market, supported by strategic initiatives and partnerships aimed at enhancing vaccine production capabilities. The region's market growth is further fueled by the establishment of manufacturing facilities and the expansion of production lines for bioprocessing systems. The market is moderately competitive, with key players like F. Hoffmann-La Roche AG, Nova Biomedical Corporation, and Thermo Fisher Scientific leading the charge. Innovations such as the CrisBio technology platform and collaborations for automated bioprocess monitoring solutions are indicative of the dynamic developments within the industry. These factors collectively underscore the market's potential for robust growth over the forecast period.
Bioprocess Analyzers Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Interest in the Development of Advanced Medicines and Vaccines
-
1.2.2 Increasing Demand for Biologics
-
-
1.3 Market Restraints
-
1.3.1 Complexity of Upstream and Downstream Processing and Strict Regulations
-
1.3.2 High Cost of Raw Materials
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Instruments
-
2.1.2 Consumables
-
-
2.2 By Application
-
2.2.1 Antibiotics
-
2.2.2 Recombinant Proteins
-
2.2.3 Biosimilars
-
2.2.4 Other Applications
-
-
2.3 By Type
-
2.3.1 Substrate Analysis
-
2.3.2 Metabolite Analysis
-
2.3.3 Concentration Detection
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Bioprocess Analyzers Market Size FAQs
How big is the Bioprocess Analyzers Market?
The Bioprocess Analyzers Market size is expected to reach USD 2.00 billion in 2024 and grow at a CAGR of 15.80% to reach USD 4.17 billion by 2029.
What is the current Bioprocess Analyzers Market size?
In 2024, the Bioprocess Analyzers Market size is expected to reach USD 2.00 billion.